Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ravizza Farmaceutici is an established Italian pharmaceutical company headquartered in Muggiò, Italy. Founded in 1920, the company has a long history of developing and marketing a variety of pharmaceutical products, particularly in the fields of respiratory medicine, neurology, and inflammation. The company was acquired by BASF in 1994 and integrated into its Knoll pharmaceutical division, which was later acquired by Abbott Laboratories in 2001. Currently, Ravizza Farmaceutici operates as a subsidiary of Abbott, focusing on the Italian healthcare market. Its portfolio has historically included well-known brands such as Flomax (morniflumate) and Ravizina.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ravizza Farmaceutici.